www.Allergan.com • NYSE: AGN

THIS IS ALLERGAN

I am proud to introduce you to Allergan plc (NYSE:AGN), a bold, global

pharmaceutical company and a leader in a new industry model – Growth Pharma. Our

world-class team of 16,000+ colleagues develops, manufactures and commercializes

innovative branded pharmaceuticals, devices, biologic and tissue products for

patients around the world. Fueled by our Open Science R&D model and one of the

broadest development pipelines in the industry, we are committed to innovation and

addressing unmet medical needs.

Allergan is also one of the world’s fastest growing pharmaceutical companies – and we

are committed to making it the best place to work and achieve career goals. Together,

we are carving new paths and taking bold, decisive actions that deliver results and

better outcomes for patients, providers, and colleagues. We are Allergan.

ALLERGAN:

A FOCUSED GROWTH PHARMA LEADER

A MESSAGE FROM BRENT SAUNDERS Allergan Chairman, President and CEO

CATEGORY LEADERSHIPMaintain/achieve # 1 & 2position in key therapeutic areas

Innovation driven to address unmet needs

STRONG TOP-LINE GROWTHSustainable top line revenue growth

Targeted geographic expansion

Leading global brands

CUSTOMERINTIMACYDeep knowledge of therapeutic area environment

Highly responsive/service oriented

Industry leading pipeline to sustaintherapeutic area growth and leadership

Development Powerhouse

GROWTHPHARMA

Simplified & reliable manufacturing network OPEN SCIENCE R&D

Sales and marketing engine

Industry leading operating margins

OPERATIONAL EXCELLENCE

SER-120Adult Nocturia

BotoxIndication X

Ceftazidime/AvibactamHABP/VABP

Aztreonam/AvibactamGram Neg Infect

UlipristalFibroids

EstradiolVaginal Cream VVA & Dyspareunia

M1 Agonist Alzheimer’s disease

M4 Agonist Alzheimer’s disease

M1/M4 AgonistAlzheimer's Disease

Donepezil-SolifenacinAlzheimer’s Disease

NMDA Part Co-Agonist Co-Agon Major Depression

Atogepant Migraine Prevention

ApimostinelMajor Depression

VraylarMultiple

SempranaAcute Migraine

BotoxMajor Depression

UbrogepantAcute Migraine

RapastinelMajor Depression

NR2Br AntagonistOCD/Autism

EvogliptinNASH

LinzessDelayed Release IBS-C

Relamorelin Diabetic Gastroparesis

FxR AgonistNASH

CenicrivirocNASH

BrazikumabUlcerative Colitis

BrazikumabCrohn’s Disease

SetipiprantAndrogenic Alopecia

Volbella Tear Trough

Aczone ComboAcne Vulgaris

Skin Quattro Device Delivery for Facial Fillers

HA ThreadsForehead & Neck

Larger Inspira TE Breast Augmentation

BoNT-A MT10109LAesthetics Facial Lines

LXR-B agonistAtopic Dermatitis

MicrocellBreast Augmentation

Phoenix Breast Augmentation

ROR-y T InhibitorMultiple (Psoriasis)

Latanoprost Lower Eyelid Fat

KybellaPeri-axilary Fat

BotoxPlatysma

VoLite Filler Fine Lines

Voluma Filler for Chin

Voluma Filler for Temple  

Voluma Plus Facial Volumes

Voluma GlobalMalar Augmentation

Volift Nasolabial Folds

BotoxForehead Lines  

SarecyclineAcne 

Voluma Filler for Nose

Inspira TF2Breast Augmentation

EarfoldProminent Ears

BotoxMasseter

Botox Multiple

RituximabNon-Hodgkin Lymphoma

ArmourThyroidHypothyroidism

NeurostimAllergic Rhinitis

TrastuzumabMultiple Cancer

BevacizumabMultiple Cancer

Urology CNS Eye Care

Other(Biosimilars, Cardiovascular and other)

Gastro-enterology

2

13

26

172

2 7

6

Anti-Infective

Aesthetics & Dermatology

Women’s Health

AbiciparAMD

Bimatoprost SR Glaucoma

Chemokine AntagonistDry Eye

FPR2 AgonistDry Eye Disease

Pilo/Oxy Presbyopia

AbiciparDME 

Brimo DDS Atrophic AMD

Cyclosporine SRDry Eye

Cortisol Analog Dry Eye Disease

Periocular RingGlaucoma/Other

Omega 3 OTC Dry Eye

Ganfort MDPF

DARPin® SR AMD

Optive Fusion China Dry Eye

Optive Fusion MDPF

REFRESH Artificial Tears

Optogenetic Gene Therapy Retinitis Pigmentosa

OUR OPEN SCIENCE

PIPELINEAllergan is an industry leader in Open Science, the Company’s R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. We have leveraged this approach to build one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage programs in development. Learn more at Allergan.com.

17WOMEN’S

HEALTH

OUR GLOBAL FRANCHISES SPAN

7 THERAPEUTIC AREAS

USAFall River, MABranchburg, NJ Cincinnati, OHNorthern CA (Biologics)Irvine, CA (Biologics)Waco, TXJersey City, NJRockaway, NJBridgewater, NJIrvine, CA

COSTA RICASan Jose

BRAZILGuarulhos

IRELANDClonshaughWestportWestport

BELGIUMLiege

GERMANYWeiterstadt

FRANCEPringyPringy

MANUFACTURING

CHINABeijingShanghai

JAPANTokyo

UKLiverpoolMarlow

R&D

SINGAPORESingapore

NETWORK

OUR EXCEPTIONAL MANUFACTURING AND R&D

ANTI-INFECTIVES

CARDIOLOGY

EYE CARE

TM

(deoxycholic acid) injection 10 mg/mL

AESTHETICS, DERMATOLOGY &

REGENERATIVE MEDICINE

CENTRAL NERVOUS

SYSTEMUROLOGYGASTRO-

ENTEROLOGY

™

72 mcg •145 mcg • 290 mcg

We commit to these responsible pricing ideals for our branded therapeutics:

For more information, visit: www.Allergan.com/SocialContract

OUR SOCIAL CONTRACT WITH PATIENTS

We are committed to investing billions of dollars, at risk, to develop life-enhancing innovations.

1. INVEST & INNOVATE

2. ACCESS & PRICING

3. QUALITY & SAFETY We commit to intensely monitoring the safety of our medicines and promptly reporting and acting on new safety data. We also commit to maintaining high standards of quality while maintaining a continuous supply of our medicines.

4. EDUCATION We are committed to appropriately educating physicians about our medicines so that they can be used in the right patients for the right conditions.

These are our commitments to the medical professionals and patients who count on us to continue finding new treatments for their most pressing medical needs.

We commit to making these branded therapeutic treatments accessible and affordable to patients while also ensuring that we can continue to meet our “invest and innovate” obligations outlined in Principle 1.

U.S. ADMINISTRATIVE HEADQUARTERSMorris Corporate Center III • 400 Interpace ParkwayParsippany, NJ 07054 • USA

CORPORATE HEADQUARTERSClonshaugh Business & Technology ParkClonshaugh, Dublin D17 E400 • Ireland

Allergan® and its design are trademarks of Allergan, Inc. © 2017 Allergan. All rights reserved. www.Allergan.com • NYSE: AGN

Our Company’s success is powered by

our commitment to being Bold for Life.

Together, we are people of action.

Four actions describe how we work when

we’re at our best. They define our culture

and clarify what it means to live bold.

MEANS DOING WHAT IS RIGHTBOLD

BUILD BRIDGES

POWER IDEAS

DRIVE RESULTS

ACT FAST

We